Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Belgium
|
| gptkbp:focusesOn |
vaccines
|
| gptkbp:foundedBy |
GlaxoSmithKline
|
| gptkbp:headquartersLocation |
gptkb:Rixensart,_Belgium
|
| https://www.w3.org/2000/01/rdf-schema#label |
GlaxoSmithKline Biologicals
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProduct |
gptkb:Synflorix
gptkb:Cervarix gptkb:Mosquirix |
| gptkbp:numberOfEmployees |
over 7,000
|
| gptkbp:parentCompany |
GlaxoSmithKline
|
| gptkbp:subsidiary |
GlaxoSmithKline
|
| gptkbp:website |
https://www.gsk.com/en-gb/about-us/our-locations/belgium/
|
| gptkbp:bfsParent |
gptkb:Pandemrix
gptkb:Jean-Paul_Prieels |
| gptkbp:bfsLayer |
7
|